Francesco Saraceni Selected Research

Francesco Saraceni Research Topics

10	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2023 - 09/2014
6	Leukemia 10/2023 - 07/2017
3	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 12/2023 - 10/2020
3	Multiple Myeloma 10/2022 - 09/2017
3	Lymphoma (Lymphomas) 01/2018 - 09/2017
1	VEXAS syndrome 02/2024
1	Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive) 12/2023
1	Central Pontine Myelinolysis 12/2021
1	Lung Injury 02/2021
1	Bronchiolitis Obliterans Syndrome 02/2021
1	COVID-19 02/2021
1	Graft vs Host Disease (Graft-Versus-Host Disease) 02/2021
1	Residual Neoplasm 10/2020
1	Neoplasms (Cancer) 01/2018
1	Cytopenia 01/2018
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 07/2017
1	Abscess 12/2014

4	fludarabineIBA 10/2023 - 01/2018
4	Busulfan (Busulfex)FDA Link 10/2023 - 01/2018
4	Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric 10/2023 - 01/2018
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2023 - 10/2018
2	treosulfanIBA 10/2023 - 01/2019
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2021 - 01/2018
2	plerixafor FDA Link 01/2018 - 09/2017
2	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2018 - 09/2014
1	Inotuzumab OzogamicinIBA 12/2023
1	Bortezomib (Velcade)FDA Link 10/2022
1	Lenalidomide (CC 5013)FDA Link 10/2022
1	Thalidomide (Thalomid)FDA Link 10/2022
1	ruxolitinibIBA 02/2021
1	CytokinesIBA 02/2021
1	Chimeric Antigen ReceptorsIBA 10/2020
1	Tyrosine Kinase InhibitorsIBA 10/2020
1	Monoclonal AntibodiesIBA 10/2020
1	AntigensIBA 10/2020
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 10/2020
1	Bispecific AntibodiesIBA 10/2020
1	Melphalan (Alkeran)FDA LinkGeneric 01/2018
1	Etoposide (VP 16)FDA LinkGeneric 01/2018
1	Carmustine (FIVB)FDA Link 01/2018
1	Filgrastim (Neupogen)FDA Link 09/2017
1	Biosimilar PharmaceuticalsIBA 09/2017
1	Gemtuzumab (Mylotarg)FDA Link 09/2014

7	Stem Cell Transplantation 10/2022 - 09/2014
5	Hematopoietic Stem Cell Transplantation 12/2023 - 01/2018
5	Therapeutics 10/2022 - 09/2014
2	Transplantation 01/2021 - 01/2019
2	Hematopoietic Stem Cell Mobilization 01/2021 - 09/2017
1	Cell Transplantation 02/2024
1	Drug Therapy (Chemotherapy) 01/2018
1	Laparotomy 12/2014